LifeStance Health Group (NASDAQ:LFST - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.02, Zacks reports. The company had revenue of $325.50 million during the quarter, compared to the consensus estimate of $313.96 million. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.66%. LifeStance Health Group updated its Q1 2025 guidance to EPS and its FY 2025 guidance to EPS.
LifeStance Health Group Stock Performance
LFST traded up $0.12 during trading on Monday, hitting $7.91. 2,187,247 shares of the company traded hands, compared to its average volume of 1,259,818. The firm has a market cap of $3.03 billion, a P/E ratio of -30.42 and a beta of 1.28. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group has a one year low of $4.64 and a one year high of $8.61. The stock's fifty day moving average is $7.80 and its 200 day moving average is $7.24.
Wall Street Analyst Weigh In
LFST has been the subject of several recent research reports. Barclays boosted their price objective on LifeStance Health Group from $6.00 to $7.00 and gave the company an "underweight" rating in a report on Monday, November 11th. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 price objective on the stock in a report on Monday, December 16th. Finally, William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a report on Friday. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $8.70.
View Our Latest Stock Analysis on LFST
LifeStance Health Group Company Profile
(
Get Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Further Reading
Before you consider LifeStance Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.
While LifeStance Health Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
